PaceMate Names NIH-Funded Researcher and Cardiac Electrophysiologist Benjamin A. Steinberg, MD, MHS, FACP, FACC, FHRS as Chief Medical Officer.
Market-Leading Cardiac Monitoring Platform Adds Clinical Innovator to Accelerate Next-Generation AI Solutions
TAMPA, Fla.–(BUSINESS WIRE)–PaceMate, a tech-enabled cardiac device monitoring platform managing care for more than 2.3 million patients at health systems nationwide, announced the appointment of Dr. Benjamin A. Steinberg as Chief Medical Officer. A nationally recognized leader in cardiac electrophysiology, NIH-funded researcher, and author of nearly 200 peer-reviewed publications, Dr. Steinberg brings to PaceMate a rare combination of clinical depth, research rigor, and real-world expertise in applying AI and data science to cardiac device management.
The appointment reflects PaceMate’s continued investment in clinical leadership. Built on a research-grade dataset aggregating discrete device, EHR, and operational data at scale, PaceMate is positioned to translate that data advantage into actionable clinical intelligence. As CMO, Dr. Steinberg will help shape PaceMate’s clinical direction, connecting its proprietary AI analytics engine to the clinical and scientific community and ensuring the platform remains aligned with the needs of device clinics, health systems, and the patients they serve.
“Dr. Steinberg sits at a rare intersection: a practicing electrophysiologist who also leads AI research at scale,” said JR Finkelmeier, Chief Executive Officer, PaceMate. “His work has shaped how the field approaches personalized care for patients with implantable devices, and now that expertise lives inside PaceMate. We have a CMO who has lived the clinical and operational challenges our platform is built to solve. Dr. Steinberg is central to where PaceMate is headed.”
Dr. Steinberg serves as Director of Cardiac Electrophysiology at Denver Health Medical Center and Associate Professor of Medicine at the University of Colorado Anschutz Medical Campus, where he treats patients and leads NIH-funded research applying machine learning and AI to arrhythmia diagnosis and implantable device management. He earned his medical degree from Johns Hopkins University School of Medicine, completed residency on the Osler Service at The Johns Hopkins Hospital, and trained in cardiology and electrophysiology at Duke University. He is principal investigator on multiple active NIH grants focused on personalized stroke risk stratification in atrial fibrillation and explainable AI for cardiac applications. Dr. Steinberg also holds leadership roles within the American College of Cardiology and Heart Rhythm Society and serves on multiple editorial boards.
“PaceMate has created a truly differentiated platform that reflects how device clinics operate in the real world, supporting millions of patients with a data infrastructure capable of delivering insights at an unprecedented scale,” said Dr. Steinberg. “Throughout my career as both a clinician and researcher, I have focused on using data to personalize patient care and improve outcomes. PaceMate provides the opportunity to turn that vision into reality, and I’m excited to join the team and help advance the future of clinical intelligence in remote cardiac monitoring.”
PaceMate partners with integrated delivery networks and academic health systems across the country, offering extensive EHR connectivity and 14 vendor integrations that support all major cardiac device manufacturers. Powered by its proprietary in-house alerts analytics engine, the platform delivers an average 75% increase in revenue capture within six months while reducing physician alert burden by 30%. Backed by 18 peer-reviewed publications, PaceMate stands among the few cardiac remote monitoring platforms with a validated clinical evidence base. With the addition of Dr. Steinberg as Chief Medical Officer, PaceMate further reinforces its leadership at the intersection of clinical science and advanced technology in cardiac remote monitoring.
About PaceMate
PaceMate is a leading technology-enabled cardiac device monitoring platform trusted by integrated delivery networks and academic health systems across the United States. Designed to be both EHR-agnostic and vendor-neutral, the platform integrates all major cardiac device manufacturers and EHR systems into a single intelligent solution, enabling clinical teams to streamline workflows, gain population-level insights, and deliver personalized patient care at scale. PaceMate currently supports the management of more than 2.3 million patients and is powered by the industry’s only research-grade cardiac dataset combining discrete device, EHR, and operational data. Learn more at PaceMate.com.
Contacts
Media Contact
Nushin Samii
VP of Marketing
Nushin.samii@pacemate.com
PaceMate.com
